Links from this page to related variants, conditions, drugs and topics are not included for automated readers. Those connections are the Gene Knowledge Graph and are licensed as data: https://www.mygenelog.com/license

Standard

Lymphocyte count

HLA-C · rs2524108

Strength of the evidence

2 / 4

Its strongest genetic-study result is p = 10−43, with 3 associations in the GWAS Catalog.

How this is scored

4: ClinVar disease-causing, reviewed by an expert panel or a guideline (3–4 stars). 3: ClinVar, several labs agreeing (2 stars), or a genetic study at p ≤ 10−50. 2: ClinVar from one lab (1 star), or p ≤ 10−20. 1: ClinVar submitted without criteria (0 stars), or genome-wide significance (p ≤ 5×10−8). The higher of the two counts. It says how solid the evidence is, not whether it matters for a particular person.

What the study found

Who was studied 408,112 British individuals.

The effect Each copy of the G allele shifted the measure 0.0508 lower (95% confidence interval 0.044-0.058); p = 6 × 10−44.

How common The G allele had a frequency of about 27% in the people studied.

Where it sits Chromosome 6, band 6p21.33 — between genes, 4.1 kb from HLA-C.

How common each version is

CG
Korean KRGDB
C 82.5% · G 17.5%
Korean Korea4K
C 81.5% · G 18.5%
Japanese ToMMo
C 86.5% · G 13.5%
World gnomAD
C 79.2% · G 20.8%
World 1000 Genomes
C 83.5% · G 16.5%
World TOPMed
C 79.8% · G 20.2%

By ancestry gnomAD

East Asian
C 89.2% · G 10.8%
European (non-Finnish)
C 73.5% · G 26.6%
African / African American
C 86.4% · G 13.6%
South Asian
C 78.5% · G 21.6%
Admixed American (Latino)
C 84.4% · G 15.6%
Middle Eastern
C 73.1% · G 26.9%
Finnish
C 80.9% · G 19.1%
Ashkenazi Jewish
C 63.7% · G 36.3%

The share of all copies of this position that are each version. Source: the population studies published in dbSNP (US NCBI); each row names its study. The ancestry rows are gnomAD's own groups (via Ensembl), as the survey defines them, not races.

What each result means

C/C No copy of the version the research linked to Lymphocyte count. This is the starting point the study compared everyone against.
C/G One copy of the version the research linked to Lymphocyte count. That is a smaller link than two copies.
G/G Two copies of the version the research linked to Lymphocyte count. That is the strongest link of the three results. A link in a study is not a diagnosis.
Source

Quoting this page

Licensed CC BY-NC 4.0: free to read, share and adapt for non-commercial use, naming MyGeneLog™ and linking the exact page. Commercial use, including training or serving a commercial AI system, needs a licence — https://www.mygenelog.com/license

Lymphocyte count (rs2524108). MyGeneLog™. https://www.mygenelog.com/variants/rs2524108

← See all variants